Market Research Logo

Global Platinum based Cancer Drug Market Insights, Forecast to 2025

Global Platinum based Cancer Drug Market Insights, Forecast to 2025

This report studies the Platinum based Cancer Drug market status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top manufacturers in global and major regions, and splits the Platinum based Cancer Drug market by product type and applications/end industries.

In the last several years, global market of platinum based cancer drug developed smoothly, with an average growth rate of 5.76%. In 2017, global revenue of platinum based cancer drug is nearly 1285 M USD; the actual sales are about 25236 K Units

The major players in global Platinum based Cancer Drug market include
Sanofi
Hengrui Medicine
ASK Pharma
Yi Bai Pharmaceutical
Qilu Pharmaceutical
Teva
Pfizer
Dr Reddy's Laboratories
Mylan
Sun Pharma
Novartis
Debiopharm
Accord Healthcare
SK Chemicals

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth rate of Platinum based Cancer Drug in these regions, from 2013 to 2025 (forecast), covering
North America
Europe
Asia-Pacific
South America
Middle East & Africa

On the basis of product, the Platinum based Cancer Drug market is primarily split into
Cisplatin
Oxaliplatin
Carboplatin
Other

On the basis on the end users/applications, this report covers
Colorectal Cancer


1 Study Coverage
1.1 Platinum based Cancer Drug Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Platinum based Cancer Drug Market Size Growth Rate by Type
1.4.2 Cisplatin
1.4.3 Oxaliplatin
1.4.4 Carboplatin
1.5 Market by Application
1.5.1 Global Platinum based Cancer Drug Market Size Growth Rate by Application
1.5.2 Colorectal Cancer
1.5.3 Ovarian Cancer
1.5.4 Lung Cancer
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Platinum based Cancer Drug Market Size
2.1.1 Global Platinum based Cancer Drug Revenue 2013-2025
2.1.2 Global Platinum based Cancer Drug Sales 2013-2025
2.2 Platinum based Cancer Drug Growth Rate by Regions
2.2.1 Global Platinum based Cancer Drug Sales by Regions
2.2.2 Global Platinum based Cancer Drug Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Platinum based Cancer Drug Sales by Manufacturers
3.1.1 Platinum based Cancer Drug Sales by Manufacturers
3.1.2 Platinum based Cancer Drug Sales Market Share by Manufacturers
3.2 Platinum based Cancer Drug Revenue by Manufacturers
3.2.1 Platinum based Cancer Drug Revenue by Manufacturers (2017-2018)
3.2.2 Platinum based Cancer Drug Revenue Share by Manufacturers (2017-2018)
3.2.3 Global Platinum based Cancer Drug Market Concentration Ratio
3.3 Platinum based Cancer Drug Price by Manufacturers
3.4 Platinum based Cancer Drug Headquarters and Established
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Platinum based Cancer Drug Sales by Type
4.2 Global Platinum based Cancer Drug Revenue by Type
4.3 Platinum based Cancer Drug Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Platinum based Cancer Drug Breakdown Data by Application
6 North America
6.1 North America Platinum based Cancer Drug by Countries
6.1.1 North America Platinum based Cancer Drug Sales by Countries
6.1.2 North America Platinum based Cancer Drug Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Platinum based Cancer Drug by Type
6.3 North America Platinum based Cancer Drug by Application
6.4 North America Platinum based Cancer Drug by Company
7 Europe
7.1 Europe Platinum based Cancer Drug by Countries
7.1.1 Europe Platinum based Cancer Drug Sales by Countries
7.1.2 Europe Platinum based Cancer Drug Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Platinum based Cancer Drug by Type
7.3 Europe Platinum based Cancer Drug by Application
7.4 Europe Platinum based Cancer Drug by Company
8 Asia Pacific
8.1 Asia Pacific Platinum based Cancer Drug by Countries
8.1.1 Asia Pacific Platinum based Cancer Drug Sales by Countries
8.1.2 Asia Pacific Platinum based Cancer Drug Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Southeast Asia
8.2 Asia Pacific Platinum based Cancer Drug by Type
8.3 Asia Pacific Platinum based Cancer Drug by Application
8.4 Asia Pacific Platinum based Cancer Drug by Company
9 Central & South America
9.1 Central & South America Platinum based Cancer Drug by Countries
9.1.1 Central & South America Platinum based Cancer Drug Sales by Countries
9.1.2 Central & South America Platinum based Cancer Drug Revenue by Countries
9.1.3 Brazil
9.1.4 Argentina
9.1.5 Columbia
9.2 Central & South America Platinum based Cancer Drug by Type
9.3 Central & South America Platinum based Cancer Drug by Application
9.4 Central & South America Platinum based Cancer Drug by Company
10 Middle East and Africa
10.1 Middle East and Africa Platinum based Cancer Drug by Countries
10.1.1 Middle East and Africa Platinum based Cancer Drug Sales by Countries
10.1.2 Middle East and Africa Platinum based Cancer Drug Revenue by Countries
10.1.3 Saudi Arabia
10.1.4 UAE
10.1.5 Egypt
10.1.6 South Africa
10.1.7 Nigeria
10.2 Middle East and Africa Platinum based Cancer Drug by Type
10.3 Middle East and Africa Platinum based Cancer Drug by Application
10.4 Middle East and Africa Platinum based Cancer Drug by Company
11 Analysis of Platinum based Cancer Drug Industry Key Manufacturers
11.1 Sanofi
11.1.1 Company Profile
11.1.2 Product Information
11.1.3 Sales, Price, Revenue, Gross Margin and Market Share
11.2 Hengrui Medicine
11.2.1 Company Profile
11.2.2 Product Information
11.2.3 Sales, Price, Revenue, Gross Margin and Market Share
11.3 ASK Pharma
11.3.1 Company Profile
11.3.2 Product Information
11.3.3 Sales, Price, Revenue, Gross Margin and Market Share
11.4 Yi Bai Pharmaceutical
11.4.1 Company Profile
11.4.2 Product Information
11.4.3 Sales, Price, Revenue, Gross Margin and Market Share
11.5 Qilu Pharmaceutical
11.5.1 Company Profile
11.5.2 Product Information
11.5.3 Sales, Price, Revenue, Gross Margin and Market Share
11.6 Teva
11.6.1 Company Profile
11.6.2 Product Information
11.6.3 Sales, Price, Revenue, Gross Margin and Market Share
11.7 Pfizer
11.7.1 Company Profile
11.7.2 Product Information
11.7.3 Sales, Price, Revenue, Gross Margin and Market Share
11.8 Dr Reddy¡¯s Laboratories
11.8.1 Company Profile
11.8.2 Product Information
11.8.3 Sales, Price, Revenue, Gross Margin and Market Share
11.9 Mylan
11.9.1 Company Profile
11.9.2 Product Information
11.9.3 Sales, Price, Revenue, Gross Margin and Market Share
11.10 Sun Pharma
11.10.1 Company Profile
11.10.2 Product Information
11.10.3 Sales, Price, Revenue, Gross Margin and Market Share
11.11 Novartis
11.11.1 Company Profile
11.11.2 Product Information
11.11.3 Sales, Price, Revenue, Gross Margin and Market Share
11.12 Debiopharm
11.12.1 Company Profile
11.12.2 Product Information
11.12.3 Sales, Price, Revenue, Gross Margin and Market Share
11.13 Accord Healthcare
11.13.1 Company Profile
11.13.2 Product Information
11.13.3 Sales, Price, Revenue, Gross Margin and Market Share
11.14 SK Chemicals
11.14.1 Company Profile
11.14.2 Product Information
11.14.3 Sales, Price, Revenue, Gross Margin and Market Share
12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Technology Progress/Risk
12.1.1 New Active Substance Launches 2011-2015 by Indication
12.1.2 Rapid Uptake of New Immune-oncology Drugs Reflects Their Remarkable Clinical Profile and Expansion of Indications
12.1.3 Technology Progress in Related Industry
12.2 Cancer Patients Analysis
12.2.1 Key Facts
12.2.2 Cancer Incidence and Mortality Analysis
12.3 Key World Economic Indicators
13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Platinum based Cancer Drug R&D Cost Analysis
13.1.2 Platinum based Cancer Drug Customers
13.2 Sales Channels Analysis
13.2.2 Distributors
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
Figure Platinum based Cancer Drug Product Picture
Table Platinum based Cancer Drug Key Market Segments
Table Key Manufacturers Platinum based Cancer Drug Covered
Table Global Platinum based Cancer Drug Market Size Growth Rate by Type (2018-2025) (K Unit) & (M USD)
Figure Global Platinum based Cancer Drug Sales Market Share by Type in 2017
Figure Cisplatin Product Picture
Figure Oxaliplatin Product Picture
Figure Carboplatin Product Picture
Table Global Platinum based Cancer Drug Market Size Growth Rate by Application (2018-2025) (K Unit)
Figure Colorectal Cancer
Figure Ovarian Cancer
Figure Lung Cancer
Figure Platinum based Cancer Drug Report Years Considered
Figure Global Platinum based Cancer Drug Market Size 2013-2025 (M USD)
Figure Global Platinum based Cancer Drug Sales 2013-2025 (K Unit)
Table Global Platinum based Cancer Drug Market Size by Regions 2018-2025 (K Unit) & (M USD)
Table Global Platinum based Cancer Drug Sales by Regions 2013-2018 (K Unit)
Table Global Platinum based Cancer Drug Sales by Regions 2019-2025 (K Unit)
Figure Global Platinum based Cancer Drug Sales Market Share by Regions 2013-2025
Figure 2017 Global Platinum based Cancer Drug Sales Market Share by Regions
Table Global Platinum based Cancer Drug Revenue by Regions 2013-2018 (M USD)
Table Global Platinum based Cancer Drug Revenue by Regions 2019-2025 (M USD)
Figure Global Platinum based Cancer Drug Revenue Market Share by Regions 2013-2025
Figure Global Platinum based Cancer Drug Revenue Market Share by Regions in 2017
Table Global Platinum based Cancer Drug Sales by Manufacturers (2017-2018) (K Unit)
Table Global Platinum based Cancer Drug Sales Share by Manufacturers (2017-2018)
Figure Global Platinum based Cancer Drug Sales Share by Manufacturers in 2017
Table Platinum based Cancer Drug Revenue by Manufacturers (2017-2018) (Million USD)
Table Platinum based Cancer Drug Revenue Share by Manufacturers (2017-2018)
Figure Platinum based Cancer Drug Value Share by Manufacturers in 2017
Figure 2017 Platinum based Cancer Drug Revenue Market Share of Top 5 Manufacturers
Table Key Manufacturers Platinum based Cancer Drug Price (2017-2018) (USD/Unit)
Table Table Manufacturers Platinum based Cancer Drug Headquarters and Established
Table Global Platinum based Cancer Drug Sales by Type (2013-2018) (K Unit)
Table Global Platinum based Cancer Drug Sales by Type (2019-2025) (K Unit)
Figure Global Platinum based Cancer Drug Sales Market Share by Type (2013-2025)
Figure Global Platinum based Cancer Drug Sales Market Share by Type in 2017
Table Global Platinum based Cancer Drug Revenue by Type (2013-2018) (M USD)
Table Global Platinum based Cancer Drug Revenue by Type (2019-2025) (M USD)
Figure Global Platinum based Cancer Drug Revenue Market Share by Type (2013-2025)
Figure Global Platinum based Cancer Drug Revenue Market Share by Type in 2017
Table Platinum based Cancer Drug Price by Type 2013-2018 (USD/Unit)
Table Global Platinum based Cancer Drug Market Size Growth Rate by Application (2018-2025) (K Unit)
Table Global Platinum based Cancer Drug Sales by Application (2013-2018) (K Unit)
Table Global Platinum based Cancer Drug Sales by Application (2019-2025) (K Unit)
Figure Global Platinum based Cancer Drug Sales Share by Application (2013-2025)
Figure Global Platinum based Cancer Drug Market Share by Application in 2017
Figure North America Platinum based Cancer Drug Sales Growth Rate 2013-2025 (K Unit)
Figure North America Platinum based Cancer Drug Revenue Growth Rate 2013-2025 (M USD)
Table North America Platinum based Cancer Drug Sales by Countries (2013-2018) (K Unit)
Table North America Platinum based Cancer Drug Sales Market Share by Countries (2013-2018)
Figure North America Platinum based Cancer Drug Sales Market Share by Countries in 2018
Table North America Platinum based Cancer Drug Revenue by Countries (2013-2018) (M USD)
Table North America Platinum based Cancer Drug Revenue Market Share by Countries (2013-2018)
Figure North America Platinum based Cancer Drug Revenue Market Share by Countries in 2018
Figure United States Platinum based Cancer Drug Sales Growth Rate (2013-2025) (K Unit)
Figure United States Platinum based Cancer Drug Revenue Growth Rate (2013-2025) (M USD)
Figure Canada Platinum based Cancer Drug Sales Growth Rate (2013-2025) (K Unit)
Figure Canada Platinum based Cancer Drug Revenue Growth Rate (2013-2025) (M USD)
Figure Mexico Platinum based Cancer Drug Sales Growth Rate (2013-2025) (K Unit)
Figure Mexico Platinum based Cancer Drug Revenue Growth Rate (2013-2025) (M USD)
Table North America Platinum based Cancer Drug Sales by Type (2013-2018) (K Unit)
Table North America Platinum based Cancer Drug Sales Market Share by Type (2013-2018)
Figure 2017 North America Platinum based Cancer Drug Market Share by Type
Table North America Platinum based Cancer Drug Sales by Application (2013-2018) (K Unit)
Table North America Platinum based Cancer Drug Sales Market Share by Application (2013-2018)
Figure 2017 North America Platinum based Cancer Drug Market Share by Application
Table North America Platinum based Cancer Drug Sales by Company (2017-2018) (K Unit)
Table North America Platinum based Cancer Drug Sales Market Share by Company (2017-2018)
Figure North America Platinum based Cancer Drug Sales Market Share by Company in 2017
Figure Europe Platinum based Cancer Drug Sales Growth Rate 2013-2025 (K Unit)
Figure Europe Platinum based Cancer Drug Revenue Growth Rate 2013-2025 (M USD)
Table Europe Platinum based Cancer Drug Sales by Countries (2013-2018) (K Unit)
Table Europe Platinum based Cancer Drug Sales Market Share by Countries (2013-2018)
Figure 2017 Europe Platinum based Cancer Drug Sales Market Share by Countries
Table Europe Platinum based Cancer Drug Revenue by Countries (2013-2018) (M USD)
Table Europe Platinum based Cancer Drug Revenue Market Share by Countries (2013-2018)
Figure 2017 Europe Platinum based Cancer Drug Revenue Market Share by Countries
Figure Germany Platinum based Cancer Drug Sales Growth Rate (2013-2025) (K Unit)
Figure Germany Platinum based Cancer Drug Revenue Growth Rate (2013-2025) (M USD)
Figure France Platinum based Cancer Drug Sales Growth Rate (2013-2025) (K Unit)
Figure France Platinum based Cancer Drug Revenue Growth Rate (2013-2025) (M USD)
Figure UK Platinum based Cancer Drug Sales Growth Rate (2013-2025) (K Unit)
Figure UK Platinum based Cancer Drug Revenue Growth Rate (2013-2025) (M USD)
Figure Italy Platinum based Cancer Drug Sales Growth Rate (2013-2025) (K Unit)
Figure Italy Platinum based Cancer Drug Revenue Growth Rate (2013-2025) (M USD)
Figure Russia Platinum based Cancer Drug Sales Growth Rate (2013-2025) (K Unit)
Figure Russia Platinum based Cancer Drug Revenue Growth Rate (2013-2025) (M USD)
Table Europe Platinum based Cancer Drug Sales by Type (2013-2018) (K Unit)
Table Europe Platinum based Cancer Drug Sales Market Share by Type (2013-2025)
Figure 2017 Europe Platinum based Cancer Drug Market Share by Type
Table Europe Platinum based Cancer Drug Sales by Application (2013-2025) (K Unit)
Table Europe Platinum based Cancer Drug Sales Market Share by Application (2013-2025)
Figure 2017 Europe Platinum based Cancer Drug Market Share by Application
Table Europe Platinum based Cancer Drug Sales by Company (2017-2018) (K Unit)
Table Europe Platinum based Cancer Drug Sales Market Share by Company (2017-2018)
Figure Europe Platinum based Cancer Drug Sales Market Share by Company in 2017
Figure Asia Pacific Platinum based Cancer Drug Sales Growth Rate 2013-2025 (K Unit)
Figure Asia Pacific Platinum based Cancer Drug Revenue Growth Rate 2013-2025 (M USD)
Table Asia Pacific Platinum based Cancer Drug Sales by Countries (2013-2018) (K Unit)
Table Asia Pacific Platinum based Cancer Drug Sales Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Platinum based Cancer Drug Sales Market Share by Countries
Table Asia Pacific Platinum based Cancer Drug Revenue by Countries (2013-2025) (M USD)
Table Asia Pacific Platinum based Cancer Drug Revenue Market Share by Countries (2013-2025)
Figure 2017 Asia Pacific Platinum based Cancer Drug Revenue Market Share by Countries
Figure China Platinum based Cancer Drug Sales Growth Rate (2013-2025) (K Unit)
Figure China Platinum based Cancer Drug Revenue Growth Rate (2013-2025) (M USD)
Figure Japan Platinum based Cancer Drug Sales Growth Rate (2013-2025) (K Unit)
Figure Japan Platinum based Cancer Drug Revenue Growth Rate (2013-2025) (M USD)
Figure Korea Platinum based Cancer Drug Sales Growth Rate (2013-2025) (K Unit)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report